Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis

Show full item record



Permalink

http://hdl.handle.net/10138/232796

Citation

Tesi , B , Lagerstedt-Robinson , K , Chiang , S C C , Ben Bdira , E , Abboud , M , Belen , B , Devecioglu , O , Fadoo , Z , Yeoh , A E J , Erichsen , H C , Mottonen , M , Akar , H H , Hästbacka , J , Kaya , Z , Nunes , S , Patiroglu , T , Sabel , M , Saribeyoglu , E T , Tvedt , T H , Unal , E , Unal , S , Unuvar , A , Meeths , M , Henter , J-I , Nordenskjold , M & Bryceson , Y T 2015 , ' Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis ' , Genome medicine , vol. 7 , 130 . https://doi.org/10.1186/s13073-015-0244-1

Title: Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis
Author: Tesi, Bianca; Lagerstedt-Robinson, Kristina; Chiang, Samuel C. C.; Ben Bdira, Eya; Abboud, Miguel; Belen, Burcu; Devecioglu, Omer; Fadoo, Zehra; Yeoh, Allen E. J.; Erichsen, Hans Christian; Mottonen, Merja; Akar, Himmet Haluk; Hästbacka, Johanna; Kaya, Zuhre; Nunes, Susana; Patiroglu, Turkan; Sabel, Magnus; Saribeyoglu, Ebru Tugrul; Tvedt, Tor Henrik; Unal, Ekrem; Unal, Sule; Unuvar, Aysegul; Meeths, Marie; Henter, Jan-Inge; Nordenskjold, Magnus; Bryceson, Yenan T.
Contributor: University of Helsinki, Clinicum
Date: 2015-12-18
Language: eng
Number of pages: 13
Belongs to series: Genome medicine
ISSN: 1756-994X
URI: http://hdl.handle.net/10138/232796
Abstract: Background: Hemophagocytic lymphohistiocytosis (HLH) is a rapid-onset, potentially fatal hyperinflammatory syndrome. A prompt molecular diagnosis is crucial for appropriate clinical management. Here, we validated and prospectively evaluated a targeted high-throughput sequencing approach for HLH diagnostics. Methods: A high-throughput sequencing strategy of 12 genes linked to HLH was validated in 13 patients with previously identified HLH-associated mutations and prospectively evaluated in 58 HLH patients. Moreover, 2504 healthy individuals from the 1000 Genomes project were analyzed in silico for variants in the same genes. Results: Analyses revealed a mutation detection sensitivity of 97.3 %, an average coverage per gene of 98.0 %, and adequate coverage over 98.6 % of sites previously reported as mutated in these genes. In the prospective cohort, we achieved a diagnosis in 22 out of 58 patients (38 %). Genetically undiagnosed HLH patients had a later age at onset and manifested higher frequencies of known secondary HLH triggers. Rare, putatively pathogenic monoallelic variants were identified in nine patients. However, such monoallelic variants were not enriched compared with healthy individuals. Conclusions: We have established a comprehensive high-throughput platform for genetic screening of patients with HLH. Almost all cases with reduced natural killer cell function received a diagnosis, but the majority of the prospective cases remain genetically unexplained, highlighting genetic heterogeneity and environmental impact within HLH. Moreover, in silico analyses of the genetic variation affecting HLH-related genes in the general population suggest caution with respect to interpreting causality between monoallelic mutations and HLH. A complete understanding of the genetic susceptibility to HLH thus requires further in-depth investigations, including genome sequencing and detailed immunological characterization.
Subject: CHEDIAK-HIGASHI-SYNDROME
GRISCELLI SYNDROME TYPE-2
T-CELL
PRIMARY IMMUNODEFICIENCIES
RAB27A MUTATIONS
ADULT-ONSET
DEFICIENCY
PROTEIN
PERFORIN
MUNC13-4
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1186_2Fs13073_015_0244_1.pdf 717.3Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record